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Abstract
Phenotypic change is a hallmark of bacterial adaptation during chronic infection. In the case of chronic Pseudomonas
aeruginosa lung infection in patients with cystic fibrosis, well-characterized phenotypic variants include mucoid and small
colony variants (SCVs). It has previously been shown that SCVs can be reproducibly isolated from the murine lung following
the establishment of chronic infection with mucoid P. aeruginosa strain NH57388A. Using a combination of single-molecule
real-time (PacBio) and Illumina sequencing we identify a large genomic inversion in the SCV through recombination between
homologous regions of two rRNA operons and an associated truncation of one of the 16S rRNA genes and suggest this may
be the genetic switch for conversion to the SCV phenotype. This phenotypic conversion is associated with large-scale
transcriptional changes distributed throughout the genome. This global rewiring of the cellular transcriptomic output results
in changes to normally differentially regulated genes that modulate resistance to oxidative stress, central metabolism and
virulence. These changes are of clinical relevance because the appearance of SCVs during chronic infection is associated
with declining lung function.
DATA SUMMARY
All genome sequences are deposited in NCBI GenBank
under accession numbers CP013477, CP013478 and
CP013479. Transcriptome data are deposited at the EMBL-
EBI ENA database under study number PRJEB12456.
INTRODUCTION
Phenotypic variation is a hallmark of adaptation to the host
during chronic bacterial infection. There is considerable
interest in slow-growing subpopulations of bacteria, termed
small colony variants (SCVs), due to their association with
persistent infections [1, 2]. The SCV variant is common to
diverse bacteria and is characterized by phenotypes includ-
ing reduced growth, increased biofilm production [3], anti-
biotic resistance and hyperpiliation. SCVs have been
described for a wide range of bacterial genera and species
including Staphylococcus aureus [4, 5], Staphylococcus epi-
dermidis [6], Streptococcus sp. [7, 8], Enterococcus [9], Liste-
ria [10], Burkholderia [11], Salmonella [12], Brucella [13],
Lactobacillus, Serratia and Neisseria [14]. In the case of
Pseudomonas aeruginosa, SCVs are commonly associated
with chronic infection of the lung in patients with cystic
fibrosis (CF) [15, 16].
P. aeruginosa is the major proven cause of mortality in
patients with CF and chronic infection leads to a progres-
sive decline in pulmonary function and inevitably respira-
tory failure [17–19]. Despite intensive anti-pseudomonal
chemotherapy greatly improving the prognosis for CF
patients [20], the current median age at death for CF
patients is around 30 years in developed countries [21].
The frequent failure of antibiotic therapy and host defences
to eradicate P. aeruginosa from the CF lung is thought to
be largely due to the increased antibiotic tolerance when
growing in the biofilm state and the appearance of mucoid
phenotypic variants that are a hallmark of adaptation in
the chronically infected lung. A further complicating factor
is the appearance of highly adherent SCVs that are adept
at biofilm formation [15, 22, 23]. P. aeruginosa SCVs may
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display high intracellular levels of c-di-GMP [23–27],
enhanced biofilm formation, high fimbrial expression,
repression of flagellar genes, resistance to phagocytosis and
enhanced antibiotic resistance. Most importantly, the
appearance of SCVs in the CF lung correlates with poor
clinical outcome [11, 28–31].
There are a range of genetic changes that have been
shown to be responsible for the phenotypic switch to the
SCV phenotype in P. aeruginosa, including mutations in
the Wsp system and yfiBNR operon that form part of the
c-di-GMP regulatory system in P. aeruginosa [26, 32–34].
However, identification of the major clinically relevant
pathways of conversion to the SCV phenotype is compli-
cated by the unstable phenotype displayed by many SCVs
with reversion to a normal colony phenotype frequently
observed, preventing successful comparative genetic stud-
ies on clinical SCVs and their closely related parent
strains. In S. aureus, which also forms clinically relevant
SCVs, recent work has shown that a reversible large-scale
chromosomal inversion is the genetic basis of the switch
between a normal colony and SCV isolated from the same
patient [35]. In addition, S. aureus SCVs, which are com-
monly isolated from the CF lung, are highly resistant to
oxidative stress, suggesting that conversion to the SCV
phenotype may be an adaptation to the environment in
chronically inflamed host tissue [36].
In the present study, we have attempted to determine the
genetic basis of phenotypic conversion from the mucoid to
the SCV phenotype for SCVs isolated from the chronic lung
infection model described by Bayes et al. [37]. For two
SCVs isolated from this work, we have shown through a
combination of single-molecule real-time (SMRT; Pacific
Biosciences) and Illumina sequencing that a large and stable
chromosomal inversion and associated truncation of a 16S
rRNA gene accompanies conversion to the SCV phenotype.
The phenotypic switch is characterized by transcriptional
changes to a large number of genes that most notably
include downregulation of several genes encoding metabolic
enzymes, DNA repair proteins and heat shock proteins and
upregulation of genes encoding proteins involved in the
response to oxidative stress. The absence of other obvious
genetic changes suggests that this chromosomal inversion
may be the genetic basis of conversion to the SCV
phenotype.
RESULTS
P. aeruginosa SCVs are commonly isolated from patients
with CF and have been isolated in vitro as well as from
experimental infection models following aminoglycoside
treatment [16, 28]. Bayes et al. describe the isolation and
partial characterization of SCVs isolated from a chronic
murine P. aeruginosa lung infection model [37]. In this
model, animals were inoculated with P. aeruginosa strain
NH57388A (NHMuc), a mucoid clinical isolate, embedded
in agar beads. NHMuc has a known mutation in the gene
encoding the anti-sigma factor MucA, which results in
alginate overproduction [38, 39]. Recovered bacteria from
lung homogenate samples display two distinct colony mor-
phologies: typical large mucoid colonies identical in mor-
phology to the inoculating strain and SCVs. Mucoid
colonies were evident after 24 h of growth on agar plates at
37

C with SCVs visible only after 48 h of growth on agar
plates [37].
To understand the genetic basis of this phenotypic change,
we initially performed Illumina HiSeq whole-genome
sequencing and genomic comparison between NHMuc and
two separate SCVs (SCVJan and SCVFeb) isolated from
independent in vivo experiments. However, despite their
gross phenotypic differences, this analysis failed to identify
any genetic differences between the SCVs and the parent
strain.
Next, we used the ultra-long reads produced by SMRT Pac-
Bio sequencing to attempt to identify any large-scale
genome rearrangements that could drive conversion to the
SCV phenotype. Using this technique we identified a large-
scale genomic inversion accompanying conversion from the
parent mucoid to SCV phenotype in both SCVJan and
SCVFeb. Closer inspection of the genome sequence identi-
fied the start and end points of the inversion, which for
both SCVJan and SCVFeb begins at the first rRNA operon
(0.72 Mbp) and ends at the third rRNA operon (5.21 Mbp).
Exact chromosomal breakpoints were identified in the cor-
responding 16S rRNA genes by performing a MAUVE
breakpoint analysis (Fig. 1). Furthermore, genome analysis
revealed a 250 bp shortened 16S rRNA gene (16St) in both
SCV strains, which is reflected in the reduced genome sizes
of the SCVs (SCVJan 6 213 026 bp, SCVFeb 6 213 029 bp;
Fig. 2a) compared to the parent strain, NHmuc
(6 213 276 bp; Fig. 2b). There were no further differences in
the number of protein coding genes (5619), rRNAs (12) or
tRNAs (57) between SCVs and the parent strain. No SNPs
could be identified in protein coding genes. A similar
genome inversion was not identified (using a PCR-based
IMPACT STATEMENT
Chronic lung infection with Pseudomonas aeruginosa is
the major proven cause of mortality in patients with cys-
tic fibrosis. This is despite the use of aggressive antibiotic
therapy, which although effective in managing infection,
frequently fails to eradicate P. aeruginosa. Adaptation to
the lung is associated with the appearance of small col-
ony variants (SCVs), which are highly adherent and adept
at forming biofilms. Here we show that SCVs isolated
from the murine lung during chronic infection, and in the
absence of antibiotic therapy, show transcriptional
changes that enhance the oxidative stress response and
increase virulence. Sequencing of the genomes of the
SCVs and parent strain shows that the SCVs contain a
large genomic inversion relative to the parent strain.
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strategy) in a mucoid strain (NHMucJan) that was pheno-
typically identical to the parent strain (NHMuc) and iso-
lated from the same chronic infection model as SCVJan
(Fig. S1, available in the online version of this article). Inter-
estingly, comparison of the SCVJan and SCVFeb genomes
with that of an SCV (SCV20265) isolated from a CF patient
[40, 41], which has recently been sequenced by PacBio
sequencing, revealed an almost identical chromosomal
inversion. However, in SCV20265 the inversion was not
accompanied by truncation of the 16S rRNA gene in the
third rRNA operon (Fig. 1).
Transcriptional and phenotypic changes on
conversion to the SCV phenotype
To determine the transcriptional changes associated with
conversion to the SCV phenotype, we performed RNA
sequencing (RNA-Seq) analysis of the parent strain,
NHMuc, and two SCV strains grown in Lysogeny broth
(LB). Initial analysis showed that SCVJan and SCVFeb
have highly similar gene expression profiles that are dis-
tinct from that of NHMuc. RNA-Seq data for all strains
were collected in triplicate and data for SCVJan and
SCVFeb were combined to compare with NHMuc. Relative
Fig. 1. A common large-scale chromosomal inversion in three P. aeruginosa strains is the genetic basis for conversion to the SCV phe-
notype. From top to bottom strains NHMuC, SCVJan, SCVFeb and SCV20265 are displayed. Dashed lines indicate the inversion break-
points present in the 16S rRNA genes. An inversion with highly similar breakpoints is present in the genome of strain SCV20265, an
SCV isolated from a patient with CF. Within strains SCVJan and SCVFeb, a unique truncated version of the 16S rRNA gene (16St) could
be resolved, which could not be detected in strain SCV20265.
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to NHMuc, 190 genes showed >2-fold upregulation and
364 genes showed >2-fold downregulation in SCVJan/
SCVFeb (Table S1). Interestingly, the transcriptional
changes associated with genomic inversion and that drive
conversion to the SCV phenotype are not restricted to
genes close to or within the inversion breakpoints, with
major upregulated and downregulated genes distributed
relatively evenly throughout the genome (Fig. 3).
Major functional classes of genes downregulated in SCVJan/
SCVFeb include those involved in energy metabolism,
amino acid and protein biosynthesis, DNA replication and
recombination, and cell wall/lipopolysaccharide/capsule
biosynthesis, which together are consistent with the slow
growth rate observed for SCVs. Notably, genes encoding
heat shock proteins and other molecular chaperones (IbpA,
GrpE, HtpG, ClpB, DnaK, GroES, DnaJ and ClpX) are
highly represented among the most strongly downregulated
genes in the SCVs (Table 1). Conversely, genes that function
in the response to oxidative stress and those that encode
secreted virulence factors are largely upregulated in
SCVJan/SCVFeb. Indeed, five of the ten most highly upreg-
ulated genes in SCVJan/SCVFeb are those associated with
the response to oxidative stress (Table 2). Highly upreg-
ulated oxidative stress genes include katA [41], which enco-
des the major catalase of P. aeruginosa, ahpB, ahpC and
ahpF [42, 43], which encode subunits of alkyl hydroperox-
ide reductase, and trxB2, which encodes thioredoxin reduc-
tase 2 [44, 45]. Consistent with the observed transcriptional
changes, catalase activity was strongly increased in SCVJan
relative to NHMuc (Fig. 4a).
Genes encoding a number of secreted virulence factors
such as the proteases LasA, LasB and AprA, the frucose-
binding lectin LecB [46] and the chitin binding protein
CbpD and chitinase ChiC [47] were also highly upreg-
ulated. Similarly, genes encoding hydrogen cyanide syn-
thase and a number of enzymes that function in phenazine
biosynthesis are also upregulated (Table S1) [25, 48–51].
Phenazines have previously been shown to enhance killing
of Caenorhabditis elegans by P. aeruginosa [52]. The
apparent increase in the production of virulence factors by
SCVJan/SCVFeb relative to NHMuc suggests increased vir-
ulence of the SCV. To directly test this we used an infec-
tion model based on infection of the murine macrophage
cell line J774A.1. Cell death of J774A.1 through lactate
Fig. 2. Chromosomal maps of P. aeruginosa NHmuc (a) and SCVJan/SCVFeb (b). The circular genomes of both strains are shown.
Genomes of both SCV strains are 250 bp smaller than the parental strain NHmuc. Exact genome sizes are given in the lower left cor-
ner. In blue (circle 1) genes lying on the forward strand are shown and in red (circle 2) those on the reverse strand. In circle 3 tRNA
genes are shown in brown, often clustered together with green rRNA genes, which have been additionally marked by vertical arrows.
The red arrow shows the transposition of rRNA operon 3 in addition to that of a large tRNA region (green ellipse) due to the described
chromosomal inversion. Circle 4 shows the GC content, whereas in circle 5 a GC skew is shown. Numbers of coding sequences, rRNAs,
tRNAs and non-coding RNAs are identical in all strains (upper right corner according to GenBank submission).
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dehydrogenase (LDH) release was measured 4 and 10 h
after infection with NHMuc and SCVJan. At 4 h, levels of
LDH release were similar for NHMuc and SCVJan,
whereas at 10 h LDH release was significantly increased for
SCVJan (96 vs 38%, P<0.0001; Fig. 4b). To determine if
the increased virulence of the SCV observed against a
murine cell line translated to increased virulence in an ani-
mal model of infection, we used an invertebrate model of
infection using the larva of the wax moth Galleria mello-
nella. Similar to the macrophage infection assay, SCVJan
displayed increased virulence in the G. mellonella infection
model. Mortality of larvae was measured 24, 48 and 72 h
after infection. No significant differences in mortality were
detected at 24 or 48 h, whereas at 72 hmortality was 86
and 63% (P<0.04) for SCVJan- and NHMuc-infected lar-
vae, respectively (Fig. 4c). Data from both infection models
indicate that SCVJan shows increased virulence, relative to
NHMuc, which is consistent with the phenotype of SCVs
obtained from the human host [29, 53].
DISCUSSION
In this work we show that P. aeruginosa SCVs isolated from
a chronic murine lung infection model display a general
upregulation of virulence-associated genes, relative to the
mucoid parent strain, and increased virulence, which may
begin to explain the link between the appearance of SCVs in
chronic lung infection and the associated decline in lung
function [54]. In addition, the immediate upregulation of
genes that mediate the response to oxidative stress suggests
why the isolated SCVs are rapidly selected for in a chronic
infection model in which the host immune system is
strongly activated.
A key strength of our study was the availability of both the
parent strain used to establish infection in a chronic infec-
tion model and the derived SCVs that evolved during infec-
tion. This allowed for a meaningful comparative genetic
analysis to be performed to probe the genetic changes that
occurred on conversion to the SCV phenotype. Surprisingly,
SNPs and short insertions and deletions (indels) were not
identified in the SCV genome by Illumina sequencing, and
SMRT sequencing was subsequently used to show that the
two sequenced SCVs carried a large genomic inversion
within 16S rRNA genes. Interestingly, the transcriptional
changes associated with genomic inversion are not restricted
to genes close to or within the inversion breakpoints, but
distributed relatively evenly throughout the genome. Instead
the major changes in gene expression are largely restricted
to specific functional classes of genes including those that
mediate the response to oxidative stress, virulence, DNA
repair and recombination, the chaperone network and
metabolism. This global rewiring of the cellular transcrip-
tomic output results in concerted transcriptional changes to
these normally differentially regulated genes. However, the
mechanisms that underlie these transcriptional changes are
not clear. A study in Escherichia coli suggested that posi-
tional effects on gene expression may be due to local differ-
ences in chromosomal structuring and organization, with
DNA gyrase playing an important role at certain high-activ-
ity locations [55]. Further studies will be needed to clarify
such positional effects on gene expression in the SCV
studied here.
Other large-scale genome rearrangements including large
chromosomal inversions have previously been described in
P. aeruginosa, but these were not associated with conver-
sion to the SCV phenotype [56]. A reversible genomic
Fig. 3. Global changes in gene transcription on conversion to the SCV phenotype. Fold-changes in gene expression for SCVJan/Feb
relative to NHMuc are shown in the context of the NHMuc genome. Breakpoints that define the genomic inversion present in SCVJan
and SCVFeb are indicated by red rectangles.
Irvine et al., Microbial Genomics 2019;5
5
Downloaded from www.microbiologyresearch.org by
IP:  130.209.115.82
On: Tue, 09 Apr 2019 09:20:55
inversion has also recently been shown to mediate the
reversible conversion between normal colony and SCV
phenotypes in S. aureus [35]. However, in the case of the
SCVs isolated in our work, the SCV phenotype is stable
and revertants to the parent phenotype were not observed.
A possible explanation for this observation is that a num-
ber of genes encoding proteins involved in DNA repair
and recombination, including RecA, are downregulated in
the SCV relative to the parent strain (Table 1).
In conclusion, we have shown that a P. aeruginosa SCV that
originated in the lungs of an animal with chronic coloniza-
tion may result from a large chromosomal inversion and
associated truncation of an rRNA gene. Conversion to the
SCV phenotype was associated with large-scale transcrip-
tional changes and increased virulence.
METHODS
Genome assembly and annotation
Purified bacterial genomic DNA was prepared for sequenc-
ing on an Illumina HiSeq using Qiagen DNeasy Blood and
Tissue Kit as per the manufacturer’s protocol. Sequencing
and initial bioinformatics were performed in the Centre for
Genomic Research, University of Liverpool. Sequencing
reads were mapped to the corresponding reference genome
(annotated NH strain). SMRTbell template libraries were
prepared according to the instructions from Pacific Bioscien-
ces, following the Procedure and Checklist Greater than
10 kb Template Preparation and Sequencing. Briefly, for
preparation of 10 kb libraries, ~10 µg of genomic DNA iso-
lated from SCVJan, SCVFeb and NHmuc was sheared using
g-tubes from Covaris according to the manufacturer’s
instructions. In total, 5–10 µg of sheared genomic DNA was
end-repaired and ligated overnight to hairpin adapters apply-
ing components from the DNA/Polymerase Binding Kit P4
from Pacific Biosciences. Reactions were carried out accord-
ing to the manufacturer¢s instructions. SMRTbell template
was treated with exonuclease for removal of incompletely
formed reaction products. Conditions for annealing of
sequencing primers and binding of polymerase to purified
SMRTbell template were assessed with the Calculator in RS
Remote (Pacific Biosciences). SMRT sequencing was carried
out on the PacBio RSII (Pacific Biosciences) taking one
180min movie for each SMRT cell. In total six, six and five
SMRT cells were run respectively. Data from each SMRT cell
were assembled independently using the ‘RS_HGAP_Assem-
bly.3’ protocol included in SMRTPortal version 2.3.0 using
default parameters. Each assembly revealed the fully resolved
chromosome in one single contig. Each chromosome was cir-
cularized independently; in particular, artificial redundancies
at the ends of the contigs were removed and all chromosomes
were additionally adjusted to dnaA as the first gene. The
validity of each assembly was checked using the ‘RS_Bridge-
mapper.1’ protocol. For the purpose of this study, it has been
confirmed for each of the (repetitive) rRNA operons that
enough uniquely mapping long read exists spanning the
whole repeat structure. Finally, each genome was error-cor-
rected by a mapping of Illumina reads (paired-end reads,
100 bp) onto finished genomes using Burrows–Wheeler
Transform (BWA) [57] with subsequent variant calling using
VarScan [58]. A consensus concordance of QV60 could be
confirmed for all of the three genomes. Finally, all genomes
Fig. 4. Phenotypic characterization of SCVJan. (a) Catalase activity
assay demonstrating a marked increase in catalase activity in the SCV
as compared to the NH parent strain. (b) Percentage lactate dehydro-
genase (LDH) released from a macrophage cell line with comparison
between NHMuc and SCVJan over a 4 and 10 h time period. (c) Galleria
mellonella larvae survival over time when infected with the NHMuc
and SCVJan strains monitored over 72 h.
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were annotated using Prokka 1.8 [59]. All genome sequences
were deposited in NCBI GenBank under accession numbers
CP013477, CP013478 and CP013479. Illumina short read
data have been deposited at the EMBL-EBI ENA database
under study number PRJEB12456. The shortened 16S rRNA
gene for strains SCVJan and SCVFeb was confirmed by Pac-
Bio assembly as well as BWA mapping of Illumina reads
against the final chromosome showing uniquely mapped
reads only at that genome position (data not shown).
Genomemaps were created using DNAplotter65 [60].
Transcriptome analysis
RNA isolation of the samples was performed in triplicate.
Bacterial suspensions were grown to early stationary phase to
an OD600 of 1.8 in LB at 37

C in a shaking incubator. Then,
2ml of each suspension was pelleted at 12 000 g for 10min.
RNA was extracted from samples using a bead beating/chlo-
roform extraction method as previously described [61]. The
samples were digested with DNAse I for 1 h. Bacterial RNA
was enriched using MICROBEnrich (Life Technologies) as
per the suggested protocol. rRNA was depleted using Ribo-
Zero Magnetic Gold Kit (Epidemiology; Epicentre) as per the
manufacturer’s protocol. The precipitated sample was resus-
pended in 20 µl of RNAse-free water. The concentration of
RNA was initially determined using Nanodrop followed by
an Agilent Bioanalyser. cDNA was generated by using the
methods from the Superscript Double-Stranded cDNA Syn-
thesis Kit (Invitrogen) as per themanufacturer’s instructions.
Table 1. Highly downregulated genes in SCVs relative to NHMuc
Gene ID Fold change* P† Protein description PAO1 gene ID
NHmuc_01025  75 2.610 11 Putative acetyltransferase PA4364
mexC  53 1.110 11 RND multidrug efflux fusion protein MexC PA4599
ibpA  31 1.110 7 Heat-shock protein IbpA PA3126
algD  30 1.010 9 GDP-mannose 6-dehydrogenase AlgD PA3540
NHmuc_05385  29 8.510 8 17 kDa surface antigen PA5182
NHmuc_04138  29 1.310 10 Periplasmic metal-binding protein PA3520
grpE  25 1.210 7 Heat shock protein GrpE PA4762
htpG  23 3.610 7 Heat shock protein 90 PA1596
NHmuc_0100  23 1.810 5 Hypothetical, unclassified, unknown
clpB  21 6.510 6 ClpB protein PA4542
nfxB  21 3.710 7 Transcriptional regulator NfxB PA4600
fsxA  18 7.910 8 FxsA protein PA4387
NHmuc_04950  18 3.310 6 Molecular chaperone DnaK PA4761
NHmuc_05744  17 5.810 5 Putative lipoprotein PA5526
dapB  17 2.810 6 Dihydrodipicolinate reductase PA4759
hslV  17 4.110 7 ATP-dependent protease subunit PA5053
NHmuc_01173  16 4.710 6 Hypothetical protein PA2756
NHmuc_01024  16 6.110 7 Putative transporter PA4365
NHmuc_04180  16 3.310 6 Recombinase A PA3617
mexD  15 9.510 7 RND multidrug efflux transporter MexD PA4598
NHmuc_04776  15 6.110 6 PAS/PAC sensor signal transduction histidine kinase PA4197
rsmA  15 7.510 4 Carbon storage regulator PA0905
NHmuc_01174  14 3.310 7 Hypothetical protein PA0737
NHmuc_01594  13 2.110 5 Putative oxidoreductase PA1137
mucA  13 7.410 5 Anti-sigma factor MucA PA0763
NHmuc_03262  12 2.510 9 Hypothetical protein PA3505
NHmuc_04386  12 6.810 5 Surface antigen PA3819
amrZ  12 3.010 5 Alginate and motility regulator Z PA3385
glnA  12 5.810 6 Gutamine synthetase PA5119
groES  12 3.910 5 Co-chaperonin GroES PA4386
dnaJ  12 7.510 5 Chaperone protein DnaJ PA4760
algU  11 1.810 4 RNA polymerase sigma factor AlgU PA0762
clpX  11 4.510 4 ATP-dependent protease subunit ClpX PA1802
NHmuc_04521  11 1.910 6 Periplasmic ligand-binding sensor PA3952
*The magnitude of gene expression (fold change) was determined by comparing transcription in three replicates of NH with that in three replicates
each of the two SCV strains.
†P-values were assessed by performing an EDGE test using CLC software.
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Transcriptome analysis was performed using CLC work-
bench version 7.0 and significantly upregulated and downre-
gulated genes in SCVJan/SCVFeb versus NHMuc were
identified using the CLC software package. Transcriptome
data were deposited at the EMBL-EBI ENA database under
study number PRJEB12456.
PCR
Genomic DNA was extracted from 1.5ml of bacterial culture
using the GenElute Bacterial Genomic DNA Kit (Sigma).
Extraction was performed following the manufacturer’s rec-
ommendations and DNA was eluted into 100 µl of Elute
Solution. PCR detection of the inversion was performed with
KAPA polymerase (KAPA Long-range HotStart PCR Kit;
KAPA Biosystems) following the manufacturer’s protocol.
Two sets of primers were used: birA-F/yedZ-R and birA-F/
tyrZ-R (birA-F: CTCACCGGAGTGGAATC, yedZ-R:
TGAGCGCTTACTGCGTGTTCATCCTGG and tyrZ-R:
CCATACCGTGCTTATTAATAAGC) with the genomic
DNAs of the mucoid and SCV strains recovered from ani-
mals amplifying a fragment of 6262 or 6960 bp, respectively.
Galleria mellonella infection model
Larvae were stored on wood chips at 4

C. Overnight cultures
of bacterial strains were grown in LB, diluted 1 : 100 in the
same medium and grown to an OD600 of 0.3–0.4 as previ-
ously described [62, 63]. Cultures were centrifuged and pel-
lets were washed twice and resuspended in 10mM PBS to an
Table 2. Highly upregulated genes in SCVs relative to NHMuc
Gene ID Fold change* P† Protein description
NHmuc_04720 62 3.210 16 Hypothetical protein
trxB2 55 4.010 16 Thioredoxin reductase 2
NHmuc_01300 35 3.710 15 Putative alkyl hydroperoxide reductase
NHmuc_02350 28 1.410 26 Putative acyl carrier protein
ahpF 28 8.410 13 Alkyl hydroperoxide reductase subunit F
kata 23 7.110 10 Catalase
NHmuc_03862 20 6.910 21 Putative ankyrin domain-containing protein
NHmuc_03863 19 1.810 18 Putative hydrolase
NHmuc_00257 19 1.410 12 Putative CBS domain protein
ahpC 18 9.010 8 Alkyl hydroperoxide reductase subunit C
chiC 17 1.510 9 Chitinase
NHmuc_04185 17 6.710 6 RNA polymerase sigma factor RpoS
aprA 12 5.110 8 Alkaline metalloproteinase
NHmuc_04924 11 3.210 16 CsbD family protein
NHmuc_04718 11 1.510 11 Hypothetical protein
NHmuc_04925 11 2.210 8 Transport-associated
NHmuc_00127 10 5.910 7 Putative haemolysin
Snr1 10 4.910 7 Cytochrome c Snr1
lecB 9 5.910 8 Fucose-binding lectin PA-IIL
NHmuc_03413 8 9.110 15 Phage terminase, small subunit
katB 8 9.110 6 Catalase
NHmuc_04074 8 2.210 12 Leucyl-tRNA synthetase
phzG2_2 7 3.310 6 Pyridoxamine 5¢-phosphate oxidase
NHmuc_03358 7 2.010 8 Putative protein associated inclusion bodies
phzE1_1 7 3.210 6 Phenazine biosynthesis protein PhzE
NHmuc_00055 7 6.110 7 Hypothetical protein
NHmuc_01628 7 1.310 8 Hypothetical protein
cbpD 7 4.110 6 Chitin-binding protein CbpD
NHmuc_00546 6 2.010 3 LysR transcriptional regulator
rhlR 6 1.210 4 Transcriptional regulator RhlR
gcdH 6 4.310 5 Glutaryl-CoA dehydrogenase
NHmuc_01422 6 4.110 4 Putative DNA-binding stress protein
NHmuc_04078 6 1.510 10 Oxidoreductase probably involved in sulfite reduction
rsaL 6 1.210 2 Regulatory protein RsaL
*The magnitude of gene expression (fold change) was determined by comparing transcription in three replicates of NH with that in three replicates
each of the two SCV strains.
†P-values were assessed by performing an EDGE test using CLC software.
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OD600 of 0.1. Serial 10-fold dilutions were made in PBS. Five-
microlitre aliquots of the serial dilutions were injected using a
Hamilton syringe into G. mellonella larvae, via the hindmost
left proleg as previously described [64]. Ten larvae were
injected per dilution for each Pseudomonas strain tested. Lar-
vae were incubated in 10 cm plates at 37

C and the number
of dead larvae was scored 1–4 days after infection. For each
strain, data from three independent experiments were com-
bined. Larvae were considered dead when they displayed no
movement in response to touch. A negative control was used
in each experiment to monitor the killing due to physical
injury or infection by pathogenic contaminants. Time to
death was monitored every 24 h after infection. In any
instance where more than one control larvae died in any
given experiment, the data from infected larvae were
not used.
LDH release/cytotoxicity assay
To investigate the effect of the P. aeruginosa strains on mac-
rophages, we infected the J774A.1 cells with NH and SCV.
Bacteria were grown for 17 h to stationary phase in LB at
37

C. Immediately prior to infection, the bacteria were
diluted to exponential growth phase with culture medium
lacking phenol red and the concentration was determined by
measuring the optical density at 600 nm. Cells were grown,
washed and infected as previously documented [65]. Cells
were infected with test organisms and incubated for 4 and
10 h. LDH release was determined using the Cytotox 96 cyto-
toxicity assay kit (Promega) as per the manufacturer’s
protocol.
Catalase activity assay
Overnight cultures of bacterial strains were grown in LB,
diluted 1 : 100 in the samemedium and grown to an OD600 of
0.4. Catalase standards were prepared as per the manufac-
turer’s protocol using the OxiSelect Catalase Activity Assay
Kit, Colorimetric (Cell Biolabs). In total, 20 µl of each serial
dilution of overnight culture was added to three wells in a 96-
well plate to allow for average readings for each sample. Plate
absorbance was read at 520 nm using a FLUOstar Optima
plate reader (BMGUK).
Accessibility of biological resources
SCVs used in this study have been deposited at DSMZ
under DSM 100776–100778.
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